STOCK TITAN

Hims & Hers COO sells 14,027 shares at $28.39

Hims & Hers Health, Inc. (HIMS) reported that Chief Operating Officer Michael Chi sold Class A Common Stock in a routine insider transaction.

(Moderate)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) reported that Chief Operating Officer Michael Chi sold Class A Common Stock in a routine insider transaction. On September 15, 2026, he sold 14,027 shares at $28.39 per share in an open market or private transaction under a Rule 10b5-1 trading plan adopted on December 1, 2025. After this sale, he continued to hold 456,660 shares of Class A Common Stock directly.

Positive

  • None.

Negative

  • None.
Insider Chi Michael
Role Chief Operating Officer
Sold 14,027 shs ($398K)
Type Security Shares Price Value
Sale Class A Common Stock F1 14,027 $28.39 $398K
Holdings After Transaction: Class A Common Stock — 456,660 shares (Direct)
Footnotes (1)
  1. F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025 by the Reporting Person.
Shares sold 14,027 shares Class A Common Stock sold on September 15, 2026
Sale price per share $28.39 per share Price for the September 15, 2026 sale transaction
Shares held after transaction 456,660 shares Direct Class A Common Stock holdings after the sale
Rule 10b5-1 plan adoption date December 1, 2025 Adoption date of trading plan used for this sale
Net shares sold per Form 4 14,027 shares Net sell direction across reported transactions
Rule 10b5-1 trading plan regulatory
"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Class A Common Stock financial
"security title is listed as Class A Common Stock for the transaction"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
open market or private transaction financial
"Described as a Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HIMS report for COO Michael Chi?

Hims & Hers Health, Inc. reported that Chief Operating Officer Michael Chi sold 14,027 shares of Class A Common Stock on September 15, 2026 in an open market or private transaction at $28.39 per share.

How many HIMS shares did Michael Chi retain after the reported sale?

After the September 15, 2026 sale, Michael Chi held 456,660 shares of Hims & Hers Health, Inc. Class A Common Stock directly.

Was the HIMS insider sale by Michael Chi under a Rule 10b5-1 trading plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025 by Michael Chi.

What price did Michael Chi receive per HIMS share in this Form 4 transaction?

The reported transaction price was $28.39 per share for the 14,027 shares of Hims & Hers Health, Inc. Class A Common Stock sold on September 15, 2026.

What role does Michael Chi hold at Hims & Hers Health, Inc. (HIMS)?

Michael Chi is identified in the filing as the Chief Operating Officer of Hims & Hers Health, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chi Michael

(Last)(First)(Middle)
2269 CHESTNUT STREET, #523

(Street)
SAN FRANCISCO CALIFORNIA 94123

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock09/15/2026S(1)14,027D$28.39456,660D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025 by the Reporting Person.
Remarks:
/s/ Kimberly Mather, Attorney-in-Fact for Michael Chi09/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading